Literature DB >> 16464238

Zebrafish lacking Alzheimer presenilin enhancer 2 (Pen-2) demonstrate excessive p53-dependent apoptosis and neuronal loss.

William A Campbell1, Hongwei Yang, Henrik Zetterberg, Stéphanie Baulac, Jacqueline A Sears, Tianming Liu, Stephen T C Wong, Tao P Zhong, Weiming Xia.   

Abstract

Gamma-secretase cleavage, mediated by a complex of presenilin, presenilin enhancer (Pen-2), nicastrin, and Aph-1, is the final proteolytic step in generating amyloid beta protein found in brains of Alzheimer's disease patients and Notch intracellular domain critical for proper neuronal development. Here, we employ the zebrafish model to study the role of Pen-2 in neuronal survival. We found that (i) knockdown of Pen-2 using antisense morpholino led to a reduction of islet-1 positive neurons, (ii) Notch signaling was reduced in embryos lacking Pen-2 or other gamma-secretase components, (iii) neuronal loss in Pen-2 knockdown embryos is not as a result of a lack of neuronal precursor cells or cell proliferation, (iv) absence of Pen-2 caused massive apoptosis in the whole animal, which could be suppressed by simultaneous knockdown of the tumor suppressor p53, (v) loss of islet-1 or acetylated tubulin positive neurons in Pen-2 knockdown embryos could be partially rescued by knockdown of p53. Our results demonstrate that knockdown of Pen-2 directly induces a p53-dependent apoptotic pathway that contributes to neuronal loss and suggest that Pen-2 plays an important role in promoting neuronal cell survival and protecting from apoptosis in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16464238     DOI: 10.1111/j.1471-4159.2006.03648.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  31 in total

Review 1.  Modeling human neurodegenerative diseases in transgenic systems.

Authors:  Miguel A Gama Sosa; Rita De Gasperi; Gregory A Elder
Journal:  Hum Genet       Date:  2011-12-14       Impact factor: 4.132

2.  In vivo manifestation of Notch related phenotypes in zebrafish treated with Alzheimer's amyloid reducing gamma-secretase inhibitors.

Authors:  Ting Yang; Dilyara Arslanova; Xiaoyin Xu; Yue-Ming Li; Weiming Xia
Journal:  J Neurochem       Date:  2010-03-12       Impact factor: 5.372

3.  An automated method for cell detection in zebrafish.

Authors:  Tianming Liu; Gang Li; Jingxin Nie; Ashley Tarokh; Xiaobo Zhou; Lei Guo; Jarema Malicki; Weiming Xia; Stephen T C Wong
Journal:  Neuroinformatics       Date:  2008-02-21

Review 4.  Animal models in the drug discovery pipeline for Alzheimer's disease.

Authors:  Debby Van Dam; Peter Paul De Deyn
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 5.  γ-Secretase and its modulators: Twenty years and beyond.

Authors:  Weiming Xia
Journal:  Neurosci Lett       Date:  2019-02-11       Impact factor: 3.046

Review 6.  Presenilin: RIP and beyond.

Authors:  Matthew R Hass; Chihiro Sato; Raphael Kopan; Guojun Zhao
Journal:  Semin Cell Dev Biol       Date:  2008-11-27       Impact factor: 7.727

7.  Can zebrafish be used as animal model to study Alzheimer's disease?

Authors:  Soraya Santana; Eduardo P Rico; Javier S Burgos
Journal:  Am J Neurodegener Dis       Date:  2012-05-15

8.  MicroRNA-125b is a novel negative regulator of p53.

Authors:  Minh T N Le; Cathleen Teh; Ng Shyh-Chang; Huangming Xie; Beiyan Zhou; Vladimir Korzh; Harvey F Lodish; Bing Lim
Journal:  Genes Dev       Date:  2009-03-17       Impact factor: 11.361

9.  Phenotypic analysis of images of zebrafish treated with Alzheimer's gamma-secretase inhibitors.

Authors:  Dilyara Arslanova; Ting Yang; Xiaoyin Xu; Stephen T Wong; Corinne E Augelli-Szafran; Weiming Xia
Journal:  BMC Biotechnol       Date:  2010-03-22       Impact factor: 2.563

10.  Increased DJ-1 expression under oxidative stress and in Alzheimer's disease brains.

Authors:  Stéphanie Baulac; Hope Lu; Jennifer Strahle; Ting Yang; Matthew S Goldberg; Jie Shen; Michael G Schlossmacher; Cynthia A Lemere; Qun Lu; Weiming Xia
Journal:  Mol Neurodegener       Date:  2009-02-25       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.